|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 51.52 USD | -1.79% |
|
+6.14% | +30.23% |
| 09-04 | Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing | MT |
| 09-02 | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATRC | Delayed | |
CBOE
| ATRC | Real-time | |
Deutsche Boerse AG
| A5I | Delayed | |
Tradegate
| A5I | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 52.59 | 52.59 | 62.52 |
| Spread/Res. | -2.03% | -2.03% | -17.59% |
| Spread/Supp. | +18.46% | +44.64% | +38.83% |
| Support | 43.49 | 35.62 | 37.11 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ATRC Stock
- Charts AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions

















